Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jun;84(12):1630–1634. doi: 10.1054/bjoc.2001.1848

Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head andeck, despite loss of heterozygosity at this locus

J Snaddon 1, E K Parkinson 2, J A Craft 1, C Bartholomew 1, R Fulton 1
PMCID: PMC2363680  PMID: 11401316

Abstract

The human tumour suppressor gene PTEN located at 10q23 is mutated in a variety of tumour types particularly metastatic cases and in the germline of some individuals with Cowdens cancer predisposition syndrome. We have assessed the status of PTEN and associated pathways in cell lines derived from 19 squamous cell carcinomas of the head and neck. Loss of heterozygosity is evident at, or close to the PTEN gene in 5 cases, however there were no mutations in the remaining alleles. Furthermore by Western analysis PTEN protein levels are normal in all of these SCC-HN tumours and cell lines. To assess the possibility that PTEN may be inactivated by another mechanism, we characterized lipid phosphatase levels and from a specific PIP3 biochemical assay it is clear that PTEN is functionally active in all 19 human SCCs. Our data strongly suggest the possibility that a tumour suppressor gene associated with development of SCC-HN, other than PTEN, is located in this chromosomal region. This gene does not appear to be MXI-1, which has been implicated in some other human tumour types. PTEN is an important negative regulator of PI3Kinase, of which subunit alpha is frequently amplified in SCC-HN. To examine the possibility that PI3K is upregulated by amplification in this tumour set we assessed the phosphorylation status of Akt, a downstream target of PI3K. In all cases there is no detectable increase in Akt phosphorylation. Therefore there is no detectable defect in the PI3K pathway in SCC-HN suggesting that the reason for 3q26.3 over-representation may be due to genes other than PI3K110α. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: PTEN, LOH, carcinoma, P13K

Full Text

The Full Text of this article is available as a PDF (114.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali I. U., Schriml L. M., Dean M. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst. 1999 Nov 17;91(22):1922–1932. doi: 10.1093/jnci/91.22.1922. [DOI] [PubMed] [Google Scholar]
  2. Bockmühl U., Schmidt S., Petersen S., Petersen I. Deletionen des Chromosoms 10q--Marker für die Metastasierung bei Kopf-Hals-Karzinomen? Laryngorhinootologie. 2000 Feb;79(2):81–85. doi: 10.1055/s-2000-8787. [DOI] [PubMed] [Google Scholar]
  3. Chen Q., Samaranayake L. P., Zhou H., Xiao L. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncol. 2000 Jan;36(1):95–99. doi: 10.1016/s1368-8375(99)00068-8. [DOI] [PubMed] [Google Scholar]
  4. Cobb M. H., Goldsmith E. J. How MAP kinases are regulated. J Biol Chem. 1995 Jun 23;270(25):14843–14846. doi: 10.1074/jbc.270.25.14843. [DOI] [PubMed] [Google Scholar]
  5. Edington K. G., Loughran O. P., Berry I. J., Parkinson E. K. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog. 1995 Aug;13(4):254–265. doi: 10.1002/mc.2940130408. [DOI] [PubMed] [Google Scholar]
  6. Kubo Y., Urano Y., Hida Y., Arase S. Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of human skin. J Dermatol Sci. 1999 Apr;19(3):199–201. doi: 10.1016/s0923-1811(98)00058-9. [DOI] [PubMed] [Google Scholar]
  7. Ma Y. Y., Wei S. J., Lin Y. C., Lung J. C., Chang T. C., Whang-Peng J., Liu J. M., Yang D. M., Yang W. K., Shen C. Y. PIK3CA as an oncogene in cervical cancer. Oncogene. 2000 May 25;19(23):2739–2744. doi: 10.1038/sj.onc.1203597. [DOI] [PubMed] [Google Scholar]
  8. Maehama T., Dixon J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998 May 29;273(22):13375–13378. doi: 10.1074/jbc.273.22.13375. [DOI] [PubMed] [Google Scholar]
  9. Marsh D. J., Kum J. B., Lunetta K. L., Bennett M. J., Gorlin R. J., Ahmed S. F., Bodurtha J., Crowe C., Curtis M. A., Dasouki M. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999 Aug;8(8):1461–1472. doi: 10.1093/hmg/8.8.1461. [DOI] [PubMed] [Google Scholar]
  10. Okami K., Wu L., Riggins G., Cairns P., Goggins M., Evron E., Halachmi N., Ahrendt S. A., Reed A. L., Hilgers W. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Cancer Res. 1998 Feb 1;58(3):509–511. [PubMed] [Google Scholar]
  11. Quinn A. G., Sikkink S., Rees J. L. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res. 1994 Sep 1;54(17):4756–4759. [PubMed] [Google Scholar]
  12. Rhei E., Kang L., Bogomolniy F., Federici M. G., Borgen P. I., Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 1997 Sep 1;57(17):3657–3659. [PubMed] [Google Scholar]
  13. Rhei E., Kang L., Bogomolniy F., Federici M. G., Borgen P. I., Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 1997 Sep 1;57(17):3657–3659. [PubMed] [Google Scholar]
  14. Rheinwald J. G., Beckett M. A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981 May;41(5):1657–1663. [PubMed] [Google Scholar]
  15. Risinger J. I., Hayes A. K., Berchuck A., Barrett J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 1997 Nov 1;57(21):4736–4738. [PubMed] [Google Scholar]
  16. Shao X., Tandon R., Samara G., Kanki H., Yano H., Close L. G., Parsons R., Sato T. Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma. Int J Cancer. 1998 Aug 31;77(5):684–688. doi: 10.1002/(sici)1097-0215(19980831)77:5<684::aid-ijc4>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  17. Shayesteh L., Lu Y., Kuo W. L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G. B., Gray J. W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet. 1999 Jan;21(1):99–102. doi: 10.1038/5042. [DOI] [PubMed] [Google Scholar]
  18. Speicher M. R., Howe C., Crotty P., du Manoir S., Costa J., Ward D. C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 1995 Mar 1;55(5):1010–1013. [PubMed] [Google Scholar]
  19. Whang Y. E., Wu X., Suzuki H., Reiter R. E., Tran C., Vessella R. L., Said J. W., Isaacs W. B., Sawyers C. L. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5246–5250. doi: 10.1073/pnas.95.9.5246. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES